Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: A planning study

Simple differences in the approach to volumetric MRI-based cervix BT treatment planning can impact HR-CTV D90. Consequently, dose escalation for MRI-guided cervix BT appears feasible in this manner should clinical circumstances warrant.